Trigeminal neuralgia is the most common neuralgia affecting the orofacial region. The condition characterized by sudden, severe electric shock like pain on the face with pain free periods and is termed as refractory period.Management of this condition is achieved through various drug therapies and in some cases, surgical intervention may be required. Refractory trigeminal neuralgia is a condition that is non responsive to the traditional line of therapy. This poses a challenge to the clinicians to offer the patients alternate options for pain control in these patients. In this review, an attempt has been made to discuss the various drug therapies in the management of refractory trigeminal neuralgia.

Original languageEnglish
Pages (from-to)939-942
Number of pages4
JournalBiomedical and Pharmacology Journal
Issue number2
Publication statusPublished - 06-2021

All Science Journal Classification (ASJC) codes

  • Pharmacology


Dive into the research topics of 'Drug therapy for refractory trigeminal neuralgia - A review'. Together they form a unique fingerprint.

Cite this